Authors Posts by Daniel Dunaief

Daniel Dunaief

1642 POSTS 0 COMMENTS

An antiviral pill may be beneficial in treating COVID-19 in its early stage. Stock photo

When the pandemic first hit Suffolk County in March of 2020, health care providers tried what they could to treat COVID-19.

The treatment options may be on the verge of increasing, as Pfizer recently revealed the benefit of an antiviral pill they developed to treat the virus in its early stages.

The Pfizer pill, called paxlovid, “decreased hospitalization significantly,” said Dr. Bettina Fries, chief of the Division of Infectious Diseases at Stony Brook Medicine. “That’s exciting.”

The Pfizer pill, which would still need Food and Drug Administration authorization before medical care providers can administer it to patients, comes just a few weeks after Merck announced its antiviral pill molnupiravir was effective in treating people who contracted COVID-19.

Indeed, at the end of last week, Britain became the first country to approve the use of molnupiravir for people with underlying medical conditions, including heart disease and obesity.

“There is more information on molnupiravir as this drug was approved in the [United Kingdom] last Thursday,” Dr. Adrian Popp, chair of Infection Control at Huntington Hospital explained in an email. “It will be administered as soon as possible following a positive COVID-19 test and within five days of the onset of symptoms.”

As for Pfizer, it has not yet released data about its clinical trials to the scientific community, which means independent researchers haven’t reviewed the information.

Still, the introduction of new antiviral treatments advances the battle against the virus on another front.

“They are novel medications,” Popp added. “The speed by which they are being developed is amazing.”

Popp added that the pace at which the new Pfizer drug eliminates the virus and its symptoms is unclear because of limited data.

Fries said the Pfizer and Merck drugs were in different classes and worked differently, which means they may be most effective in combination.

In terms of side effects, Fries wouldn’t expect anything dramatic from either treatment.

Taking pills that reduce the severity of the disease also aren’t likely to reduce the body’s natural immunity to the virus.

“The immune system has already seen enough of the virus by the time you take the drug,” Fries said. Some of the patients in the trial probably had the virus for about a week, which is enough time for the immune system to recognize the invader and develop a natural resistance.

The timing of treatment with antiviral drugs determines its effectiveness. Drugs like Tamiflu, which prevents the worst symptoms of the flu, become less effective the longer the virus is in a patient.

“If you give this drug later, it will likely have less effect,” Fries said.

Additionally, Fries cautioned about overusing these drugs in future months and years, which can lead to viral resistance.

Fries believes the virus, like the flu, will continue to stick around and will return in waves.

The authorization of vaccines for children ages five to 11 will likely reduce the threat from the virus.

“A lot of parents will schlep their kids right away, especially before Thanksgiving,” Fries said. “Physicians and people who have a deeper understanding of vaccines feel comfortable” with them.

Fries recently received her third shot.

While the likelihood of children developing the worst symptoms of the disease is low, they contribute to the spread of the virus.

Additionally, the virus can mutate, which could make it “potentially a lot worse. There is [also] a low but potentially significant risk of long covid syndromes,” Fries said. “You don’t want your kid to have that. Children should be super duper healthy, not just a little bit healthy.”

Thanksgiving preparation

In terms of preparing for Thanksgiving, Fries urged everybody over 65 to get a booster, particularly if they received their initial vaccines at least six months ago.

Stony Brook Hospital is admitting patients who have been vaccinated and are over 65, in part because their initial vaccinations were over half a year ago.

“We see more and more older people presenting with the disease again,” Fries added. “Do it now so you have antibodies for Thanksgiving” particularly if a family has children returning from college.

Additionally, Fries urged residents and their families to get tested before coming together, which will reduce the risk of household transmission.

Even though Pfizer and Merck have produced drugs that may improve the treatment of COVID-19, Fries urged people to continue to get vaccinated.

“This kind of drug treatment does not make us say, ‘Okay, you don’t need to get vaccinated,’ Fries said. “Absolutely not.”

Fries noted that those people unwilling to receive an mRNA vaccine might get another option before too long.

The Novavax vaccine has “performed really well” in clinical trials, Fries said. “It is more of a traditional vaccine.” The Novavax facilities have had production problems. Once they resolve those issues, the company could apply for emergency use authorization.

David McCandlish, center, with postdoctoral researchers Anna Posfai and Juannan Zhou. Photo by Gina Motisi, 2020/ CSHL

By Daniel Dunaief

If cancer were simple, scientists would have solved the riddle and moved on to other challenges.

Often, each type of the disease involves a combination of changes that, taken together, not only lead to the progression of cancer, but also to the potential resistance to specific types of treatment.

Using math, David McCandlish, Assistant Professor at Cold Spring Harbor Laboratory, is studying how the combination of various disruptions to the genome contribute to the development of cancer.

McCandlish recently published a study with colleagues at Cold Spring Harbor Laboratory in the journal Proceedings of the National Academy of Sciences.

David McCandlish. Photo by Gina Motisi, 2020/CSHL

The research didn’t explore any single type of cancer, but, rather applied the method looking for patterns across a range of types of cancers. The notion of understanding the way these genetic alterations affect cancer is a “key motivating idea behind this work,” McCandlish said.

So far, the method has identified several candidates that need further work to confirm.

“Cancer would be a lot easier to treat if it was just one gene,” said Justin Kinney, Associate Professor at CSHL and a collaborator on the work. “It’s the combination that makes it so hard to understand.”

Ultimately, this kind of research could lead researchers and, eventually, health care professionals, to search for genetic biomarkers that indicate the likely effect of the cancer on the body. This disease playbook could help doctors anticipate and head off the next moves with various types of treatments.

“This could potentially lead to a more fundamental understanding of what makes cancer progress and that understanding would very likely open up new possibilities in cancer treatments,” Kinney said.

To be sure, at this point, the approach thus far informs basic research, which, in future years, could lead to clinical improvements.

“We are working on this method, which is very general and applicable to many different types of data,” McCandlish said. “Applications to making decisions about patients are really down the road.”

McCandlish described how he is trying to map out the space that cancer evolves in by understanding the shape of that space and integrating that with other information, such as drug susceptibility or survival time.

“We are trying to ask: how do these variables behave in different regions of this space of possibilities?” he said.

McCandlish is making this approach available to scientists in a range of fields, from those scientists interpreting and understanding the effects of mutations on the development of cancer to those researchers pursuing a more basic appreciation of how such changes affect the development and functioning of proteins.

“This is accessible to a wide array of biologists who are interested in genetics and, specifically in genetic interactions,” said McCandlish.

The main advance in this research is to take a framework called maximum entropy estimation  and improve its flexibility by using math to capture more of the underlying biological principals at work. Maximum entropy estimation is based on the idea of inferring the most uniform distribution of behaviors or outcomes with the least information that’s compatible with specific aspects of experimental observations.

Using this philosophy, scientists can derive familiar probability distributions like the bell curve and the exponential distribution. By relaxing these estimates, scientists can infer more complicated shapes.

This more subtle approach enhances the predictive value, which captures the distributions of data better, McCandlish explained. “We’re trying to capture and model cancer progression in a new and more expressive way that we hope will be able to tell us more about the underlying biology.”

The idea for this paper started when McCandlish, Kinney and  Jason Sheltzer, a former fellow at Cold Spring Harbor Laboratory and a current Assistant Professor of Surgery at Yale School of Medicine, discussed the possibilities after McCandlish attended a talk by Wei-Chia Chen, a post doctoral researcher in Kinney’s lab.

Chen will continue to pursue questions related to this effort when he starts a faculty position in the physics department at National Chung Cheng University in Taiwan this spring.

Chen will use artificial intelligence to handle higher dimensional data sets, which will allow him “to implement effective approximations” of the effect of specific combinations of genetic alterations, Kinney said.

Kinney believes teamwork made this new approach, which the high-impact, high-profile journal PNAS published, possible.

“This problem was an absolutely collaborative work that none of us individually could have done,” Kinney said. He described the work as having a “new exploratory impact” that provides a way of looking at the combination of genomic changes that “we haven’t had before.”

Working at Cold Spring Harbor Laboratory, which McCandlish has done since 2017, enables collaborations across different disciplines.

“We have this quantitative biology group, we also have people working on neuroscience, cancer, and plant biology,” McCandlish added.

McCandlish is also currently also working with Professor Zachary Lippman and his graduate student Lyndsey Aguirre to understand how multiple mutations interact to influence how the fruit on tomato plants develop.

“The idea is that there are these huge spaces of genetic possibilities where you can combine different mutations in different ways,” McCandlish explained. “We want to find those key places in that space where there’s a tipping point or a fork in the road. We want to be able to identify those places to follow up or to ask what’s special about this set of mutations that makes it such a critical decision point.”

A native of Highland Park, New Jersey, McCandlish was interested in math and science during his formative years. 

As for the work, McCandlish appreciates how it developed from the way these collative researchers interacted.

“This would never have happened if we weren’t going to each other’s talks,” he said.

Downtown Port Jefferson flooded during Superstorm Sandy. File photo

By Daniel Dunaief

Daniel Dunaief

Nine years ago, Superstorm Sandy came roaring through the area, causing flooding, knocking out power and disrupting work and school.

All these years later, New York is not prepared for other significant storms, despite studies suggesting that future, slow moving hurricanes with heavy rain could overwhelm infrastructure in and around Long Island.

“While we have dithered, New Orleans, Houston and other U.S. cities have gained federal support for regional protection strategies — which will be funded with our tax dollars,” according to an information packet created by the New York New Jersey Storm Surge Working Group. “We can’t waste another decade pursuing local responses to regional threats.”

In a ninth anniversary boat tour designed to address the challenges from a future Sandy or even a Hurricane Ida, the working group, which is chaired by School of Marine and Atmospheric Sciences Distinguished Professor at Stony Brook University Malcolm Bowman, outlined four messages.

First, the group suggested that coastal flooding presented a significant danger. Storm surge, sea level rise and storm water from extreme rain present an “existential threat” to the area.

Second, the group concluded that coastal flooding is a regional challenge that requires a regional solution. These scientists urge the two middle Atlantic states to consider creating a layered defense system, which they argue would be cost effective to protect property and the environment.

Third, and perhaps most damaging, the group concludes that the area is as vulnerable now as it was nine years ago in the days before Hurricane Sandy arrived. The group wrote that “no regional costal resilience plan” is in place to protect over 1,000 miles of the New York and New Jersey metropolitan coastline.

Fourth, the changing political climate presents an opportunity to do something. The group highlighted how a new governor of New York, the start of a new term or releected governor in New Jersey, a new mayor of New York City and the restarting of the $20 million New York and New Jersey Harbor and Tributaries Focus Area Feasibility Study, or HATS, presents a “once in a lifetime opportunity to act now to address the existential threat of costal flooding with a regional coastline resilience system that meets our social justice, environmental justice, quality of life and economic development goals.”

Bowman urged New York and New Jersey residents to consider the progress other states and countries have made.

“Houston is going ahead,” Bowman said, even while New York hasn’t taken any significant steps.

Bowman said part of the challenge in creating any change that protects the area comes from the lack of any enduring focus on a vulnerability that isn’t evident to residents on a daily basis.

“People have short memories,” Bowman said. “It’s not on their minds” even if they endured the disruption and devastation from storms like Sandy and Ida.

Necessity and the lack of deep pockets in other countries is the mother of invention.

“A lot of countries can’t afford” to rebuild the way New York and New Jersey did after Hurricane Sandy,” Bowman said. “They are forced to be more careful.”

Bowman said any major project to protect the area needs a hero who can tackle the details, navigate through the politics and execute on viable ideas.

The late Daniel Patrick Moynihan had “that kind of charisma,” Bowman said. “We need somebody who everybody sees as the hero. I don’t see that person” at this point.

For New York and New Jersey, the longer time passes without any protective measures, “the more the danger will increase,” Bowman cautioned.

Stock photo

Local health care providers were eager to start administering doses of COVID-19 vaccines to children who are 5 to 11 years old, which they can now do after the Centers for Disease Control and Prevention approved the shots for children late Tuesday night.

“We definitely saw more cases [of COVID-19] in children after school started this year,” said Dr. Sharon Nachman, chief of the Division of Pediatric Infectious Diseases at Stony Brook Children’s Hospital. “We’d like to prevent that.”

Health care providers would also like to stop household transmission, in which a member of a home spreads the virus to everyone else with whom that person lives.

“Children usually get milder forms of COVID, but they can transmit disease to people around them,” Dr. Adrian Popp, chair of Infection Control at Huntington Hospital, explained in an email. “It is not unusual for children to bring COVID in the home and then household members to be exposed and get COVID, especially if they are unvaccinated and immunocompromised.”

In considering whether parents should get shots for their children, doctors urged parents to speak with their family pediatricians.

“They are the experts in your child’s care,” Nachman said. “They’ll have the most insight into who your kid is.”

Pfizer BioNTech said the vaccines, which were a third of the dose of an adult shot, were over 90% effective against symptomatic COVID-19.

The Food and Drug Administration issued emergency use authorization for vaccines for this age group.

“Authorization of the vaccine for younger children is an important step in keeping them healthy and providing their families with peace of mind,” Dr. Lee Savio Beers, president of the group, said in a statement. “The vaccine will make it safe for children to visit friends and family members, celebrate holiday gatherings, and to resume the normal childhood activities that they’ve missed during the pandemic.”

Doctors urged parents with children who have underlying cardiac or respiratory issues to give serious consideration to vaccinations that could prevent the spread of a virus that could be especially problematic for their children.

“Someone with underlying cardiac issues, if they were to get COVID-19, would have increased risk of poor outcomes,” Nachman said. “They should be prioritized. Waiting to get COVID is not a good idea.”

The same holds true for children with asthma, who could develop more problematic symptoms from contracting the virus, Nachman said.

While the doses for children will be lower, the immune system of younger people is more reactive than that for adults, which is why pharmaceutical companies tested a lower dose in their clinical trials.

Even with the smaller volume of the vaccine, “children will still not have waning immunity,” Nachman said. “It will be just as effective” as the higher dose for adults.

Besides having more reactive and resilient immune systems, healthy children also will likely have milder side effects from the vaccine because of the lower dosage.

To be sure, every child who is in this age range and becomes eligible for the shot shouldn’t immediately receive the vaccination.

The clinical trials didn’t include children with cancer or with other immunological difficulties.

“We did not enroll [children with those conditions] in clinical trials,” so it would be difficult to know how effective the vaccine would be for them, Nachman said.

Down the road, vaccinating a classroom of children in this age category could lead to a reduction in the current restrictions designed to protect the health of students and their educators.

“It’s too soon to say the next steps,” Nachman said, which could include learning without masks. Further information about the spread of the virus after vaccinations would inform future guidelines.

Popp added that booster needs for children in the future is also unknown.

“Data will be gathered and [officials] will see if this will become necessary,” Popp said.

Rogovitz with his son Gene and his grandson Gavin surfing at Gilgo Beach in Babylon. Photo from Rogovitz

Charles Rogovitz hopes to get bottom dentures so he can relieve the stomach pain he gets from partially chewed food and can eat an apple again. Todd Warren needs to have a root canal to become eligible for a new kidney. 

Rogovitz and Warren are two of the veterans who will attend free Port Jefferson-based St. Charles Hospital’s “Give Vets a Smile” clinic on Nov. 3.

The event, which has become biannual this year and is fully booked, will provide dental care for 20 to 25 veterans.

Currently sponsored by a grant from Mother Cabrini Foundation, St. Charles has been providing an annual dental clinic for veterans since 2016.

“Our goal is to reach out to the [veterans] who do not have traditional insurance through employers,” and who “fall through the cracks,” Dr. Keri Logan, director in the Department of Dentistry at St. Charles, explained in an email. “That includes veterans who are not 100% disabled and perhaps make too much money for Medicaid, those that are homeless and the like.”

St. Charles hopes to “get as much done for them as possible,” which means that appointments typically include a visit with a hygienist as well as a dentist, Dr. Logan added.

Dr. Logan explained that veterans who do not have insurance or the means to go to a dentist regularly for routine cleanings and treatment have an increased incidence of cavities, infections and/or periodontal disease.

The event is in memory of Mark Cherches, who spent 57 years at St. Charles Hospital’s Dental Clinic and played a key role in bringing Give Veterans a Smile day to the hospital.

Dr. Cherches “heard of this from another facility a few years back and he was instrumental in giving us the idea,” Dr. Logan explained.

St. Charles is hosting the event at the Stephen B. Gold Dental Clinic.

Ruth Gold, wife of the late Stephen Gold, who was a pediatric dentist and for whom the clinic is named, appreciates the fact that the clinic is expanding with outreach programs to help the community.

The daughter of World War II veteran Milton Kalish, Gold is thankful for members of the armed forces who are “defending our country.”

Gold added that her husband would be “pleased” with the effort. “These are people who wouldn’t ordinarily go out to get their teeth checked, so this is very important.”

Rogovitz

Indeed, Rogovitz hasn’t been to a dentist in a quarter of a century.

A retired contractor who was a sergeant in the Marine Corps in Vietnam in 1967, 1968 and 1969, Rogovitz has lost his bottom teeth over the years, pulling them out when they come loose.

A resident of Babylon Village, Rogovitz has visited dentists, who estimated that it would cost $2,400 and about eight months to provide dentures for his lower jaw. He also needs dentures on his upper jaw.

“I’m hoping for the best,” Rogovitz said. “Worst comes to worst, I’ll get a lower denture and I’ll be able to masticate my food properly and not have stomach issues.”

Rogovitz has circled Nov. 3 on his calendar with highlighter in multiple colors.

The retired marine has been eating soft foods.

Rogovitz owes his life to his son Gene, who urged him to see a doctor for a general checkup in 2016. The doctor found early stage prostate cancer, which is in remission.

Rogovitz is convinced he developed cancer during his service in Vietnam, when he was given a bag of defoliant and was told to rip it open and scatter it in the grass. 

In addition, he lay in fields sprayed with Agent Orange.

Despite his health battles, Rogovitz, who calls himself a “young 74,” enjoys surfing with his son and his nine-year-old grandson, Gavin.

In addition to biting into an apple, which he hasn’t done in about 12 years, he hopes to chew on an ear of corn on the cob.

Warren

A veteran of the Navy who went on three deployments during Desert Storm, Warren has received dialysis three days a week for over 18 months.

Warren, whose rank was Petty Officer 2nd Class E5, would like to join the list for a kidney transplant.

“You have to be cleared by all these departments first,” said Warren, who is a resident of Bay Shore. “One of them is dental.”

Unable to do much walking in part because of his kidney and in part because of his congestive heart failure, Warren can’t join the organ recipient list until he has root canal.

“All of that is holding me up,” Warren said. “I have to get this root canal to get this kidney transplant.”

While St. Charles Hospital can’t guarantee any specific treatment, the dental clinic does offer root canal work as a part of that day’s free dental service for veterans.

Warren, who is 53, has sole custody of his nine-year-old son, Malachi. 

An athlete in high school who played basketball and soccer and ran track, Warren is limited in what he can do with his son in his current condition.

Warren had two teeth extracted at the Veterans Administration and is also hoping to fill that hole. When he drinks, he sometimes struggles to control the flow of liquid, causing him to choke on soda or water.

“I’m trying to do the best I can” with the missing teeth in the bottom of his mouth and the need for a root canal in the top, he said.

On behalf of himself and other veterans, Warren is grateful to St. Charles Hospital.

“I appreciate what they’re doing,” Warren said. “Let’s take care of the vets who were willing to put their lives on the line for this country.”

Qingyun Li. Photo by Xuecheng Chen

By Daniel Dunaief

Qingyun Li has a plan for carbon dioxide.

The newest hire in the Department of Geosciences at Stony Brook University, Li, who is an assistant professor, is a part of a team exploring carbon capture and storage.

“My work is expected to help reduce the amount of carbon dioxide released into the atmosphere,” Li said. It will “help people find ways to promote carbon dioxide mineralization for safer carbon dioxide storage” below the ground. While her work will help promote carbon storage, it doesn’t include capturing and transporting the gas.

By selecting sites carefully, researchers can store carbon dioxide for geologically long periods of time.

While carbon sequestration occurs on the scale of kilometers, Li often works on a minuscule level, at the nanometer to centimeter scale. Smaller scale alterations affect properties such as the permeability of the rock formation.

Li is trying to predict nucleation of a certain mineral in her computer models. She has done that for carbonate minerals, which could be what carbon dioxide becomes after it is stored in geologic formations.

A similar process of nucleation occurs in clouds, when fine particles form the nuclei around which gases condense to form water or ice.

Li used a small angle x-ray scattering synchrotron to explore important details about each particle. This technique, which doesn’t look directly at the particles, reveals through data analysis the particle’s shape, size and surface morphology and, eventually, the rate at which nucleation occurs.

For carbon dioxide sequestration, the minerals that provide nucleation start at the nanoscale, which give them a high specific surface area.

“That matters for later reactions to generate carbonate minerals,” Li said. “That’s one reason we care about the nanoscale phenomenon. The bulk minerals are generated starting from the nanoscale.” 

A larger surface area is necessary in the beginning to lead to the next steps.

Li’s work involves exploring how carbonate starts to form. Her earlier efforts looked at how calcium carbonate forms in the aqueous or water phase.

Carl Steefel, Head of the Geochemistry Department at the Lawrence Berkeley National Laboratory in California, worked with Li during her PhD research at Washington University in St. Louis. Steefel believes her research will prove productive.

“She has an approach to science that combines that one-of-its-kind capabilities for studying nucleation with a deep understanding of modeling and how these open systems involving flow and transport work,” Steefel said. “The combination of these unique capabilities, in nucleating and in understanding reactive transport modeling, will put her a very good position.”

As of now, Li plans to study carbon sequestration in natural gas formations in shale, which has nanometer sized pores. The particles can change the permeability of the rock.

Some companies, like British Petroleum and ExxonMobil, have started to explore this method as a way to reduce their carbon footprint.

While geologic carbon sequestration has shown promising potential, Li believes the process, which she said is still feasible, could be decades away. She said it may need more policy support and economic stimuli to come to fruition.

Part of the challenge is to incorporate such carbon sequestration in the established market.

Scientists working in this field are eager to ensure that the stored carbon dioxide doesn’t somehow return or escape back into the atmosphere.

“People are actively investigating possible leakage possibilities,” Li wrote in an email. “We try to design new materials to build wells that resist” carbon dioxide deterioration.

Controlling pressure and injection rates could prevent various types of leaks.

In her earlier studies, Li explored how cement deteriorates when contacted with carbon dioxide-saturated brine. She hoped to find cracks that had self-healing properties. Other studies investigated this property of concrete.

It’s possible that a mineral could form in a fracture and heal it. In natural shale, scientists sometimes see a fracture filled with a vein of carbonate. Such self healing properties could provide greater reassurance that the carbon dioxide would remain stored in rocks below the surface. Li hopes to manage that to inhibit carbon dioxide leakage.

The assistant professor grew up in Beijing, China, studied chemistry and physics in college. She majored in environmental sciences and is eager to apply what she learned to the real world.

For her PhD, Li conducted research in an engineering department where her advisor Young-Shin Jun at Washington University in St. Louis was working on a project on geologic carbon dioxide sequestration. 

In her post doctoral research at SLAC National Accelerator Laboratory, which is operated by Stanford University, Li explored mineral reactions in shale, extending on the work she did on mineral reactions in concrete as a graduate student. She sought to understand what happens after hydraulic fracturing fluids are injected into shale. These reactions can potentially change how easily the mix of gas and oil flow through a formation.

With Stony Brook building a lab she hopes is finished by next spring, Li plans to hire one graduate student and one post doctoral researcher by next fall.

She is teaching a course related to carbon sequestration this semester and is looking for collaborators not only within geoscience but also within material science and environmental engineering.

Li is looking forward to working with other researchers at the National Synchrotron Lightsource 2 at Brookhaven National Laboratory, which provides beamlines that can allow her to build on her earlier research.

Li and her husband Xuecheng Chen, who are renting an apartment in South Setauket and are looking for a home close to campus, have a three-year old son and an 11-month old daughter.

Outside the lab, Li enjoys quality time with her family. A runner, Li also plays the guzheng, which she described as a wooden box with 21 strings.

Steefel, who wrote a letter to Stony Brook supporting Li’s candidacy to join the Geosciences Department, endorsed her approach to science.

“She’s very focused and directed,” Steefel said. “She’s not running the computer codes as black boxes. She’s trying to understand what’s going on and how that relates to her experiments and to reality.”

From left, 8 1/2-year-old Dan Barsi, Jennifer Barsi, Maggie Barsi (age 4), James Barsi, and Lily Barsi (age 7)

By Daniel Dunaief

Daniel Dunaief

If your children are under the age of 12 and the Food and Drug Administration soon approves a COVID-19 vaccine, you’ll have many people to thank for the opportunity to return them to a more normal, and safer, childhood, including four-year-old Maggie, seven-year-old Lily and eight-and-a-half-year-old Dan Barsi.

The three siblings, who live in East Setauket with their parents James and Jennifer Barsi, recently participated in a clinical trial for the COVID-19 vaccine at Stony Brook Hospital. While the children don’t know whether they received vaccinations for the virus or the placebo, they are three of numerous children who volunteered to test the Pfizer-BioNTech vaccine to make sure it was safe before health care providers administer it to the broader population.

Their children “knew what they were signing up for,” said Dr. James Barsi, a pediatric orthopedic surgeon. “It’s something to help other people.”

Indeed, the community benefits from volunteers like the Barsis, who participate in clinical trials that evaluate the effectiveness of the treatment, help determine the correct doses, and reveal potential side effects before the rest of the population gets the COVID-19 vaccine or any other medicine or therapeutic intervention.

“We would never make advances in medicine without families — adults and children — volunteering to participate in clinical trials,” said Dr. Sharon Nachman, Chief of the Division of Pediatric Infectious Diseases at Stony Brook Children’s Hospital.

Some treatments for a range of illnesses or conditions look promising in the earlier stages of clinical development, such as phase 1 or phase 2. When they reach phase 3, during which researchers provide medicine to a much larger volunteer population, they sometimes fall short of expectations.

“Companies will tout drugs as the next best thing,” Dr. Nachman said. “When they get into phase 3, they are not better than standard therapy.”

Clinical trials on even an ineffective drug or one that produces side effects, however, can help pharmaceutical companies and health care providers by signaling what these professionals should look for in future treatments, Dr. Nachman added.

While volunteers of any age take risks by participating in these studies, they also have considerable medical oversight.

“They are well protected,” Dr. Nachman said. “When you participate in a clinical trial, you don’t just have two sets of eyes on you; you have 100 sets of eyes.”

Volunteers for clinical trials not only take some risk before everyone else in the community, but they also experience regular testing and monitoring.

The Barsi children, for example, had to have blood work and nose swabs. “We call it a brain swab,” Jennifer Barsi said. “The kids are so excited about getting a treat afterwards, but they still have to do the hard thing.”

Health care professionals throughout Long Island shared their appreciation for clinical trial volunteers. Without them “none of these innovative therapies and drugs would exist,” said Stephanie Solito, Research Manager of the Oncology Service Line at Catholic Health, which includes Smithtown-based St. Catherine of Siena and Port Jefferson-based St. Charles Hospital.

When Daniel Loen, Catholic Health’s Vice President of Oncology Services, takes any medicine, he appreciates that patients were “willing to sacrifice something or take on some kind of increased risk to get on a trial for the good of humanity and medicine.”

As for the specific COVID-19 pediatric trials, Dr. Nachman said parents and children have to approve to participate. Doctors talk with children in an age-appropriate way about these clinical trials.

Dan Barsi was born at 25 weeks old. He stayed in the hospital for several months and is now a healthy child.

Jennifer and James felt that this was their opportunity to give back to the next generation. The children who participated in clinical research before Dan was born helped make it possible for him to get the best treatment, and now they feel they’re doing the same thing.

Above, an AI-Grid prototype that is being built by the research team. Image courtesy of Stony Brook Power Lab

By Daniel Dunaief

The Department of Energy is energized by the possibility of developing and enhancing microgrids.

What are microgrids? They are autonomous local power systems that have small, independent and often decentralized energy sources. Often, they use renewable energy, like wind or solar power, although some use natural gas or diesel.

The DOE’s dedication to developing these microgrids may cut costs, create efficiencies and enhance energy reliability.

Peng Zhang. Photo from SBU

Peng Zhang, SUNY Empire Innovation Professor in the Department of Electrical and Computer Engineering at Stony Brook University, is leading a diverse team of researchers and industry experts who received $5 million of a $50 million investment the DOE recently made to developing, enhancing and improving microgrid technology.

Bringing together these energy experts, Zhang hopes to use artificial intelligence to create a usable, reliable and efficient source of energy, particularly during periods of power outages or disruption to the main source of energy.

“The traditional microgrid operation is based on models and human operators,” Zhang said. “We developed this data-driven or AI-based approach.”

Artificial intelligence can enhance the safety and reliability of microgrids that can receive and transmit power.

One of the objectives of the systems Zhang and his collaborators are developing will include protecting the power supplies against faults, accidents from natural disasters and cyberattacks.

“This project led by Professor Zhang is a great example demonstrating the impact of this novel research on essential infrastructure that we rely on daily,” Richard Reeder, Vice President for Research at Stony Brook University, said in a statement.

Zhang said he has verified the methods for this AI-driven approach in the lab and in a simulation environment.

“Now, it’s time to demonstrate that in more realistic, microgrid settings,” he said. He is working with microgrid representatives in Connecticut, Illinois and New York City. His team will soon work with a few representative microgrids to establish a more realistic testing environment.

The urgency to demonstrate the feasibility of this approach is high. “We need to kick the project off immediately,” said Zhang, whose team is recruiting students, postdocs, administrative staff and technicians to meet a two-year timeline.

The group hopes AI-grids can be used in different microgrids around the country. If the platform is generic enough, it can have wide applications without requiring significant modifications.

While operators of a microgrid might be able to know the ongoing status, they normally are not able to respond to contingencies manually. “It’s impossible for the operator to know the ongoing status” of power sources and power use that can change readily, Zhang explained. “That’s why we had to rely on a data driven approach.”

Additionally, end users of electricity don’t necessarily want their neighbors to know about their power needs. They may not want others who are using the same microgrid system to know what appliances or hardware are in their homes.

Instead, the system will rely on the data collected within each microgrid, which reflects the behavior at different intervals. Those energy needs can change, as people turn on a TV or unplug a wind turbine.

At the same time, the power system load and generation need to remain in balance. Microgrids that produce more energy than the system or end users need can send them to a utility grid or to neighboring microds or communities. If they don’t send that energy to others who might use it, they can lose some of that energy.

Power needs to be balanced between supply and demand. Storage systems can buffer an energy imbalance, although the cost of such storage is still high. Researchers in other departments at Stony Brook and Brookhaven National Laboratory are pursuing ways to improve efficiencies and reduce energy storage costs.

Balancing energy is challenging in most microgrids, which rely on intermittent and uncertain renewable energy sources such as sunlight. In this project, Zhang plans to connect several microgrids together into a “mega microgrid system,” that can allow any system with a surplus to push extra energy into one with a deficiency.

Microgrids aren’t currently designed to replace utilities. They may reduce electricity bills during normal operations and can become more useful during emergencies when supplies from utilities are lower.

While artificial intelligence actively runs the system, people are still involved in these programmable microgrids and can override any recommendations.

In addition to having an alarm in the event that a system is unsafe or unstable, the systems have controllers in place who can restore the system to safer functioning. The programming is flexible enough to change to meet any utility needs that differ from the original code.

In terms of cybersecurity, the system will have three lines of defense to protect against hacking.

By scanning, the system can localize an attack and mitigate it. Even if a hacker disabled one controller, the control function would pop up in a different place to replace it, which would increase the cost for the attacker.

Stony Brook created a crypto control system. “If an attacker got into our system, all the information would be useless, because he would not understand what this signal is about,” Zhang said.

While he plans to publish research from his efforts, Zhang said he and others would be careful in what they released to avoid providing hackers with information they could use to corrupt the system.

For Zhang, one of the appeals of coming to Stony Brook, where he arrived two years ago and was promoted last month to Professor from Associate Professor, was that the university has one of the best and best-funded microgrid programs in the country.

Zhang feels like he’s settled into the Stony Brook community, benefiting from interacting with his neighbors at home and with a wide range of colleagues at work. He appreciates how top scholars at the Massachusetts Institute of Technology, Harvard and national labs have proactively approached Stony Brook to establish collaborations.

Zhang is currently discussing a Phase II collaboration on a microgrid project with the Navy, which has funded his research since his arrival. “Given the federal support [from the Navy], I was able to recruit top people in the lab,” he said, including students from Columbia and Tsinghua University.

Steve Bellone. Stock photo by Rita J. Egan

Suffolk County Executive Steve Bellone (D) tested positive for COVID-19.

The County Executive, who is vaccinated and has been observing mask mandates, is unsure of how he contracted the virus.

Bellone has mild symptoms and is currently not receiving any medical treatment.

“I hope this serves as a reminder to all residents that while we are making incredible progress in the war against COVID-19, we are not done just yet,” Bellone said in a statement. “I encourage anyone who is eligible to receive their booster shot to do so.”

At this point, no other members of his office staff or his family has tested positive.

Bellone said he feels in “good health and spirits,” according to the statement. He will continue to carry out the duties of the County Executive.

Meanwhile, the percentage of positive tests on a seven-day average in Suffolk County fell below 3% on Oct. 20, dropping to 2.9%, according to the Suffolk County Department of Health.

Local health care providers have been encouraged by the overall decline in positive tests, which they attribute in part to ongoing vaccination efforts.

The Food and Drug Administration provided emergency use authorization for the Moderna booster for a specific groups of people who were fully vaccinated at least six months ago. Those groups include: people 65 years and older; people 18 through 64 who are considered at high risk; and people 18 through 64 with occupational exposure.

The FDA also approved the use of a single booster dose for people who received the Johnson & Johnson vaccine at least two months ago.

The FDA also allowed a mix and match approach to boosters, authorizing those who received one type of vaccination to choose a different booster. Local health care providers said studies have shown that people who received the J&J vaccine had a higher antibody response after receiving a Moderna booster.

“The available data suggest waning immunity in some populations who are fully vaccinated,” Acting FDA Commissioner Janet Woodccock said in a statement. “The availability of those authorized boosters is important for continued protection against COVID-19 disease.”

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said the FDA would gather additional data as quickly as possible to assess the benefits and risks of the us of booster doses in additional populations and plans to update the healthcare community and the public in the coming weeks.

For more information on vaccines in the area, residents can go to the web site: suffolkcountyny.gov/vaccine.

The web site also includes answers to frequently asked questions, such as: what are the side effects after I get the COVID-19 vaccine, is it safe to get a COVID-19 vaccine if I have an underlying medical condition, and what should I do if I am exposed to COVID-19 after being vaccinated.

Early in the pandemic, Bellone remained in quarantine and managed his responsibilities from home after Deputy County Executive Peter Scully tested positive for the virus. Bellone didn’t test positive at that point, although he, like so many others in the early days of the disease, waited days for the results of his COVID test.

Stock photo

By Daniel Dunaief

Daniel Dunaief

With 10 weeks left until the end of 2021, it seems fitting to consider what we might put into a time capsule that future generations might open to understand the strange world that was so incredibly different from the one just two years ago.

Here are a few items I’d throw into a box I’d bury or shoot into space.

— Masks. Even with so many events where people aren’t wearing masks, including huge gatherings of fans at sporting events, masks are still a part of our lives in 2021.

— A Netflix app. I’m not a streaming TV person. Most of my regular TV watching involves sports or movies (many of which I’ve seen a few times before). Still, I got caught up in the “Stranger Things” phenomenon and am now impressed with the storylines from “Madam Secretary,” which include prescient references to our withdrawal from Afghanistan and to the potential (and now real) pandemic.

— Pet paraphernalia. The number of homes with pets has climbed dramatically, as people who seemed unwilling or uninterested in having dogs are out with their collection of poop bags, leashes and pieces of dog food to entice the wayward wanderer in the right direction.

— A zoom app. Even with people returning to work, many of us are still interacting with large groups of people on a divided screen. Future generations may find all this normal and the start of eSocializing and virtual working. Many of us today are still trying to figure out where to look and avoid the temptation to scrutinize our own image.

— Cargo ships. The year started off in March with the blocking of the Suez Canal. For six days, the Ever Given kept one of the world’s most important canals from functioning, blocking container ships from going from the Mediterranean Sea to the Red Sea. As the year has progressed, concerns about shortages and supply chains have triggered fears about empty shelves.

— A small model of the Enterprise. The ship from the show “Star Trek” seems apt in a 2021 time capsule in part because William Shatner, who played the fictional Captain James T. Kirk (or admiral, if you’re also a fan of the movies), traveled briefly into space. In many ways, the science fiction of the past — a telephone that allowed you to look at someone else — is the fact of the present, with FaceTime and the aforementioned zoom.

— Competing signs. Protesting seems to have returned in full force this year. As the year comes to a close, people who do and don’t believe in vaccinations often stand on opposite sides of a road, shouting at cars, each other and the wind to get their messages across.

— A syringe. We started the year with people over 65 and in vulnerable groups getting their first doses of a vaccine that has slowed the progression of COVID-19, and we’re ending it with the distribution of booster shots for this population and, eventually, for others who received a vaccine eight months earlier.

— Take-out menus. I would throw several take-out menus, along with instructions about leaving food at a front door, into the time capsule. While numerous restaurants are operating close to their in-dining capacity, some of us are still eating the same food at home.

— An Amazon box. Barely a day goes by when I don’t see an Amazon delivery truck in the neighborhood, leaving the familiar smiling boxes at my neighbors’ front doors.

— Broken glass. I would include some carefully protected broken glass to reflect some of the divisions in the country and to remember the moment protesters stormed the capital, overwhelming the police and sending politicians scrambling for cover.

— Houses of gold. I would throw in a golden house, to show how the value of homes, particularly those outside of a city, increased amid an urban exodus.

— A Broadway playbill. My wife and I saw a musical for the first time in over two years. We were thrilled to attend “Wicked.” The combination of songs, staging, acting, and lighting transported us back to the land of Oz. Judging from the thunderous applause at the end from a fully masked audience, we were not the only ones grateful to enjoy the incredible talents of performers who must have struggled amid the shutdown.